Characteristics of nitro reduction of the carcinogenic agent, 4-nitroINOLONE N-oxide.
D000429:Alcohol Oxidoreductases / Q000378:metabolism; D000818:Animals; D001565:Benzoates / Q000378:metabolism; D002273:Carcinogens / Q000378:metabolism*; D001728:Dicumarol / Q000494:pharmacology; D005486:Flavin Mononucleotide / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009249:NADP / Q000378:metabolism; D009578:Nitrobenzenes / Q000378:metabolism; D010084:Oxidation-Reduction; D010087:Oxides / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism; D010100:Oxygen / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011804:Quinolines / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D001565:Benzoates; D002273:Carcinogens; D009578:Nitrobenzenes; D010087:Oxides; D011804:Quinolines; D009249:NADP; D008748:Methylcholanthrene; D005486:Flavin Mononucleotide; D001728:Dicumarol; D010088:Oxidoreductases; D000429:Alcohol Oxidoreductases; D010100:Oxygen; D010634:Phenobarbital